Clinical Trial Update: Abatacept for SLE Arthritis (IM101-330) [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for abatacept in systemic lupus erythematosus with arthritis (IM101-330) is terminated; results were posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus with Arthritis

Drugs mentioned

• Abatacept (abatacept)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Systemic Lupus Erythematosus Arthritis | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2021-05-13